GlassScriptPhysician profile
Roger K Khouri
NPI 1740232784
$79,919.77
in general payments reported to CMS, 2019-2025
12 companies · $40.42 in 2025
The $40.42 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $839 · 2021: $46K · 2022: $27K · 2023: $2,362 · 2024: $3,648 · 2025: $40.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,769 · Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,769.00 |
| Food and Beverage | $281.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $76,958.86 | 2020-2024 | |
| Davol INC. | $2,145.00 | 2023 | |
| Sientra, INC. | $180.28 | 2022 | |
| Stryker Corporation | $171.85 | 2023 | Spy-Phi System |
| Integra Lifesciences Corporation | $114.74 | 2019 | |
| Organogenesis INC. | $99.99 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $64.54 | 2020 | |
| Bioventus LLC | $59.10 | 2021-2025 | Xcell, Exogen Ultrasound Bone Healing System |
| Kerecis Limited | $45.30 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Strata Skin Sciences, INC. | $36.77 | 2022-2024 | Xtrac |
| Zimmer Biomet Holdings, INC. | $26.49 | 2021 | |
| Axogen | $16.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Khouri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.